Ligand- and Heterodimer-Directed Signaling of the CB1 Cannabinoid Receptor

被引:84
作者
Hudson, Brian D. [1 ]
Hebert, Terence E. [3 ]
Kelly, Melanie E. M. [1 ,2 ]
机构
[1] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 1X5, Canada
[2] Dalhousie Univ, Dept Ophthalmol, Halifax, NS B3H 1X5, Canada
[3] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada
关键词
PROTEIN-COUPLED RECEPTORS; DELTA-OPIOID RECEPTORS; BETA-ADRENERGIC RECEPTORS; HUMAN TRABECULAR MESHWORK; D-2; DOPAMINE-RECEPTORS; ENDOCANNABINOID SYSTEM; CONCURRENT STIMULATION; FUNCTIONAL SELECTIVITY; CAMP ACCUMULATION; INVERSE AGONISTS;
D O I
10.1124/mol.109.060251
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Seven-transmembrane G protein-coupled receptors (GPCRs) represent the single largest family of cell surface receptors. Signaling through these receptors is controlled by changes in the conformation of the receptor from inactive to active conformations, which in turn lead to the activation of multiple downstream signaling pathways. To facilitate greater diversity in signaling responses, many of these receptors are capable of adopting several distinct active conformations, in which each couples preferentially to its own set of downstream signaling partners. Because these unique signaling responses result from specific receptor active conformations, GPCR signaling may be directed toward these selective responses through either strength-of-signal effects resulting from partial agonism or through biased agonism and functional selectivity, resulting from the selective stabilization of one active conformation over the others. This review uses the CB 1 cannabinoid receptor as a specific example to highlight the contribution of two important aspects of GPCR function-orthosteric ligand binding and receptor heterodimerization-toward directed GPCR signaling.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 83 条
[1]   Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs [J].
Abadji, V ;
Lucas-Lenard, JM ;
Chin, CN ;
Kendall, DA .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (05) :2032-2038
[2]   Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors [J].
Agarwal, Nitin ;
Pacher, Pal ;
Tegeder, Irmgard ;
Amaya, Fumimasa ;
Constantin, Cristina E. ;
Brenner, Gary J. ;
Rubino, Tiziana ;
Michalski, Christoph W. ;
Marsicano, Giovanni ;
Monory, Krisztina ;
Mackie, Ken ;
Marian, Claudiu ;
Batkai, Sandor ;
Parolaro, Daniela ;
Fischer, Michael J. ;
Reeh, Peter ;
Kunos, George ;
Kress, Michaela ;
Lutz, Beat ;
Woolf, Clifford J. ;
Kuner, Rohini .
NATURE NEUROSCIENCE, 2007, 10 (07) :870-879
[3]   Detection of β2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET) [J].
Angers, S ;
Salahpour, A ;
Joly, E ;
Hilairet, S ;
Chelsky, D ;
Dennis, M ;
Bouvier, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3684-3689
[4]   β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors [J].
Azzi, M ;
Charest, PG ;
Angers, S ;
Rousseau, G ;
Kohout, T ;
Bouvier, M ;
Piñeyro, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) :11406-11411
[5]   Agonist and inverse agonist actions of β-blockers at the human β2-adrenoceptor provide evidence for agonist-directed signaling [J].
Baker, JG ;
Hall, IP ;
Hill, SJ .
MOLECULAR PHARMACOLOGY, 2003, 64 (06) :1357-1369
[6]  
Bambico FR, 2008, EXPERT OPIN THER TAR, V12, P1347, DOI [10.1517/14728222.12.11.1347, 10.1517/14728222.12.11.1347 ]
[7]   Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus [J].
Berg, KA ;
Maayani, S ;
Goldfarb, J ;
Scaramellini, C ;
Leff, P ;
Clarke, WP .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :94-104
[8]   The endocannabinoid system in amyotrophic lateral sclerosis [J].
Bilsland, Lynsey G. ;
Greensmith, Linda .
CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (23) :2306-2316
[9]   Differential opioid agonist regulation of the mouse mu opioid receptor [J].
Blake, AD ;
Bot, G ;
Freeman, JC ;
Reisine, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) :782-790
[10]   Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery [J].
Bond, RA ;
IJzerman, AP .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (02) :92-96